| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-26 | FY 2024
FILED 2024-12-27 | FY 2023
FILED 2023-12-29 |
|---|---|---|---|
| Revenue (Total Sales) | $305.6M | $313.9M | $296.6M |
| YoY Revenue Growth % | -2.6% | +5.8% | — |
| Gross Profit | $117.2M | $123.2M | — |
| Gross Margin % | 38.3% | 39.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $23.5M | $44.6M | $49.3M |
| Operating Margin % | 7.7% | 14.2% | 16.6% |
| Net Income (GAAP) | $12.9M | $29.6M | $34.2M |
| EBITDA (Normalized) | $29.8M | $47.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $40.3M | $47.7M | $37.4M |
| Capital Expenditures (CapEx) | $7.9M | $4.1M | — |
| Free Cash Flow (FCF) | $32.4M | $43.6M | $37.4M |
| FCF Margin % | 10.6% | 13.9% | 12.6% |
| Return on Invested Capital (ROIC %) | 14.8% | 31.5% | — |
| Cash & Short-Term Equivalents | $18.2M | $16.4M | — |
| Total Debt (Short + Long Term) | $75.8M | $12.7M | — |
| Total Stockholders' Equity | $68.1M | $115.6M | — |